Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-07-26 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion +40,000 $4.20 $168K 689,078
2021-07-26 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion · Option (right to buy) −40,000 0
2021-07-21 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion +35,000 $4.20 $147K 649,078
2021-07-21 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion · Option (right to buy) −35,000 40,000
2021-07-15 Lamb Peter EVP, Scientific Strategy & CSO Exercise or conversion +60,000 $1.90 $114K 449,467
2021-07-15 Lamb Peter EVP, Scientific Strategy & CSO Sale −60,000 $17.47 $1.0M 389,467
2021-07-15 Lamb Peter EVP, Scientific Strategy & CSO Exercise or conversion · Option (right to buy) −60,000 55,000
2021-07-06 COHEN CHARLES Director Exercise or conversion +40,000 $3.13 $125K 221,375
2021-07-06 COHEN CHARLES Director Exercise or conversion +40,000 $6.30 $252K 261,375
2021-07-06 COHEN CHARLES Director Exercise or conversion · Option (right to buy) −40,000 0
2021-07-06 COHEN CHARLES Director Exercise or conversion · Option (right to buy) −40,000 0
2021-06-17 Lamb Peter EVP, Scientific Strategy & CSO Exercise or conversion +60,000 $1.90 $114K 449,467
2021-06-17 Lamb Peter EVP, Scientific Strategy & CSO Sale −60,000 $22.18 $1.3M 389,467
2021-06-17 Lamb Peter EVP, Scientific Strategy & CSO Exercise or conversion · Option (right to buy) −60,000 115,000
2021-05-27 WYSZOMIERSKI JACK L Director Grant or award +8,299 239,888
2021-05-27 WYSZOMIERSKI JACK L Director Grant or award · Option (right to buy) +16,598 16,598
2021-05-27 FELDBAUM CARL B Director Grant or award · Option (right to buy) +33,549 33,549
2021-05-27 WILLSEY LANCE Director Grant or award · Option (right to buy) +33,549 33,549
2021-05-27 MARCHESI VINCENT T Director Grant or award +8,299 74,414
2021-05-27 MARCHESI VINCENT T Director Grant or award · Option (right to buy) +16,598 16,598

Page 31 of 42 · 836 trades